• Bestatin Dissects Arabidopsis Jasmonate Signaling

  2026-09-14

  The reference study established bestatin as a chemical-genetic probe of jasmonate signaling rather than treating it only as an aminopeptidase inhibitor. By combining transcript analysis, COI1-dependent genetic tests, developmental phenotyping, and selection of bestatin-resistant Arabidopsis mutants, the authors separated shared jasmonate responses from bestatin-specific regulatory effects.

• Baicalin: Workflow for Adult Visual Plasticity

  2026-09-14

  Baicalin offers a dose-sensitive way to test whether adult visual-cortex inhibition can be reduced to restore ocular dominance plasticity. This workflow connects intrinsic signal optical imaging, electrophysiology, GABAergic assays, and formulation controls while distinguishing neuroplasticity evidence from cancer research applications.

• Lipid Peroxidation (MDA) Assay Kit Guide

  2026-09-13

  Turn MDA measurement into a practical readout for ferroptosis, oxidative stress, and drug-resistance studies. This guide combines dual-mode detection, matrix-aware sample handling, and the OTUD3–SLC7A11 mechanism to improve assay interpretation.

• TPCA-1 as an IKK-2 Probe in RIPK1 Cell Fate

  2026-09-12

  TPCA-1 is an IKK-2 inhibitor that can help separate NF-κB-dependent inflammatory transcription from RIPK1-regulated cell death. This article integrates TPCA-1 pharmacology with a CRISPR-defined PPP1R3G–PP1γ checkpoint to improve assay design and interpretation.

• E-64 for Reliable Cysteine Protease Assays

  2026-09-12

  This scenario-based guide explains how E-64, SKU A2576, can improve mechanistic control in cell viability, proliferation, and cytotoxicity experiments. It covers concentration selection, stock handling, interpretation of discordant phenotypes, and practical criteria for choosing a reliable cysteine protease inhibitor.

• Dacarbazine: Practical Cancer Research Workflows

  2026-09-11

  Build more reproducible Dacarbazine cytotoxicity studies with controlled preparation, time-resolved dosing, and orthogonal readouts. The workflow connects cancer DNA damage pathway assays with clinically relevant exposure questions while clearly separating validated evidence from practical laboratory recommendations.

• N1-Methyl-Pseudouridine-5'-Triphosphate Workflow

  2026-09-11

  Build more informative RNA experiments with N1-Methyl-Pseudouridine-5'-Triphosphate, from controlled in vitro transcription to translation and stability testing. The workflow also shows how modified mRNA chemistry can be evaluated alongside antigen–adjuvant design in emerging mRNA vaccine development.

• Cyclosporin A (B1922): Practical Lab Workflow

  2026-09-10

  This dossier-guided article explains how to prepare, apply, and quality-control Cyclosporin A (SKU B1922) for cyclophilin, calcineurin-NFAT, mitochondrial, and cell-response studies. It is appropriate for controlled research assays but should not be used as a water-based formulation or as a substitute for model-specific animal or antiviral dosing evidence.

• Pcbp1, Mitochondrial Integrity, and B Cell Immunity

  2026-09-10

  The reference study identifies Pcbp1 as a posttranscriptional regulator that connects Fdxr mRNA control with mitochondrial complex I integrity, protein translation, and antibody production in B cells. Its findings position mitochondrial quality control as an important determinant of steady-state IgM production, germinal center development, and high-affinity humoral responses.

• Stiripentol LDH Inhibition: Practical Workflows

  2026-09-09

  Use Stiripentol as a research-grade LDH inhibitor to connect lactate flux with neuronal excitability, histone lactylation, and immune-cell behavior. This workflow-led guide covers assay setup, dosing logic, cross-domain applications, and troubleshooting without confusing mechanistic hypotheses with clinical evidence.

• C8-HSL: From Quorum Sensing to Cancer Biology

  2026-09-09

  N-octanoyl-L-Homoserine lactone, or C8-HSL, is moving from a bacterial communication probe toward a broader translational model of host–microbe signaling. This article examines its LuxR-linked biology, reported activation of PI3K/AKT/ERK in lung cancer models, and a practical strategy for converting quorum-sensing observations into reproducible infection biology research.

• S-Adenosylhomocysteine in Neural Assays

  2026-09-08

  Use S-Adenosylhomocysteine (SAH) to test whether methylation pressure contributes to radiation-altered neural differentiation, while separating metabolic effects from PI3K-STAT3-mGluR1 and p53 signaling. This practical guide covers concentration screening, SAM/SAH ratio modulation, assay controls, and troubleshooting in C17.2 and primary neural stem-cell workflows.

• TaqI Restriction Endonuclease Protocol Guide

  2026-09-07

  TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′-TCGA-3′ recognition site. It is suited to research workflows requiring sticky-end generation and quick gel-ready digestion, but it should not be used for diagnostic or medical applications.

• Epalrestat in Cell Viability Workflows

  2026-09-07

  Learn how Epalrestat (SKU B1743) can support controlled cell-viability, oxidative-stress, and Parkinson’s disease model workflows. This scenario-based guide covers formulation, experimental controls, mechanistic interpretation, and evidence-based product selection.

• Capecitabine: Mechanism and Preclinical Use

  2026-09-05

  Capecitabine is a fluoropyrimidine prodrug that is enzymatically converted to 5-fluorouracil and studied for tumor-selective chemotherapy mechanisms. Its strongest preclinical value is as a controllable tool for apoptosis, tumor-stroma modeling, and colon cancer research, while patient-derived assembloids clarify why stromal context can alter drug response.

8545 records 1/570 page Next 12345 下5页 Last page